FDA Approves Aducanumab — A Controversial Dru...

Ahead of the peak of the Perseid meteor shower, we're re-airing our first episode with host Regina G. Barber. In it, Regina and planetary scientist Melissa Rice explore all things shooting stars. They talk about the different types, where they come from and what they actually are ...  Show more

In Senegal, rice farmers are trying to kill three birds with one stone – er, fish. Rice and fish are already a natural combination; they’re even the main ingredients of thieboudienne, the delicious national dish. But could that combination also reduce a debilitating disease, boos ...  Show more

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ...  Show more

This week, the first of a new series on substance use and what you need to know about ICE - crystal meth. Does early diagnosis of ovarian cancer through screening make a difference to survival rates? And the search for an Alzheimer's disease treatment is as controversial as ever. ...  Show more

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  Show more